Photodynamic therapy in dermatology: current concepts in the treatment of skin cancer

References

• Cerbukov O, Gollnick H. Photodynamic therapy in dermatology. Euro. J. Derm. 10(7), 568–576 (2000).
   PubMedGoogle Scholar
• Cappugi P, Campolmi P, Mavilia L, Prignano F, Rossi R. Topical 5-aminolevulinic acid and photodynamic therapy in dermatology: a minireview. J. Chemother. 13(5), 494–502 (2001).
   PubMed Web of Science ®Google Scholar
• Taub AF. Photodynamic therapy in dermatology: history and horizons. J. Drugs Dermatol. 3(Suppl. 1), S8–S25 (2004).
   PubMedGoogle Scholar
• Hamzavi I, Lui H. Using light in dermatology: an update on lasers, ultraviolet phototherapy, and photodynamic therapy. Dermatol. Clin. 23(2), 199–207 (2005).
   PubMedGoogle Scholar
• Vrouenraets M, Visser GW, Snow GB, Van Dongen G. Basic principles, applications in oncology and improved selectivity of photodynamic therapy. Anticancer Res. 23(1), 505–522 (2003).
   PubMed Web of Science ®Google Scholar
• Kormeili T, Yamauchi PS, Lowe NJ. Topical photodynamic therapy in clinical dermatology. Br. J. Dermatol.150(6), 1061–1069 (2004).
   PubMedGoogle Scholar
• Kurwa HA, Barlow RJ. The role of photodynamic therapy in dermatology. Clin. Exp. Dermatol. 24(3), 143–148 (1999).
   PubMed Web of Science ®Google Scholar
• Kalka K, Merk H, Mukhtar H. Photodynamic therapy in dermatology. J. Am. Acad. Dermatol. 42(3), 389–413 (2000).
   PubMed Web of Science ®Google Scholar
• Dennis EJ, Dolmans G J, Fukura D, Kain R. Photodynamic therapy for cancer. Nature Rev. Cancer 3(1), 380–387 (2003).
   PubMedGoogle Scholar
• Taylor EL, Brown SB. The advantages of aminolevulinic acid photodynamic therapy in dermatology. J. Dermatolog. Treat. 13(Suppl. 1), S3–S11 (2002).
   Web of Science ®Google Scholar
• Stepleton M, Rhodes LE. Photosensitizers for photodynamic therapy for cutaneous disease. J. Dermatolog. Treat. 14(1), 107–112 (2003).
   PubMedGoogle Scholar
• Brown SB, Brown EA, Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 5(8), 497–508 (2004).
   PubMed Web of Science ®Google Scholar
• Gollnick SO, Lui X, Owczarczak B, Musser D. Altered expression of interleukin-6 and interleukin-10 as a result of photodynamic therapy in vivo. Cancer Res. 57(1), 3904–3909 (1997).
   PubMed Web of Science ®Google Scholar
• Sibata CH, Colussi VC, Oleinick NL, Kinsella TJ. Photodynamic therapy in oncology. Expert Opin. Pharmacother. 2(16), 917–927 (2001).
   PubMedGoogle Scholar
• Karrer S, Szeimies RM, Hohenleutner U, Landthaler M. Role of lasers and photodynamic therapy in the treatment of cutaneous malignancy. Am. J. Clin. Dermatol. 2(4), 229–237 (2001).
   PubMedGoogle Scholar
• Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J. Photochem. Photobiol. 6(1), 143–148 (1990).
   Web of Science ®Google Scholar
• Morton CA. The emerging role of 5-ALA PDT in dermatology: is PDT superior to standard treatments? J. Dermatolog. Treat. 13(Suppl. 1), S25–299 (2002).
   Web of Science ®Google Scholar
• Calin MA, Gruia M, Herascu N, Coman T. The monitoring of the accumulation of protoporphyrin IX in Walker tumours by subcutaneous administration of delta-aminolevulinic acid. J. Exp. Ther. Oncol. 4(3), 247–251 (2004).
   PubMedGoogle Scholar
• Rud E, Gederaas O, Hosget A. 5-aminolevulinic acid but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by the BETA transporters. Photochem. Photobiol. 71(1), 640–645 (2000).
   PubMed Web of Science ®Google Scholar
• Fritsch C, Homey B, Stahl W. Preferential porphyrin enrichment in solar keratoses upon topical application of delta aminolevulininc acid methylester. Photochem. Photobiol. 68, 218–221 (1998).
   PubMed Web of Science ®Google Scholar
• Kurwa HA, Yong-Gee SA, Seed PT. A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses. J. Am. Acad. Dermatol. 41, 414–418 (1999).
   PubMed Web of Science ®Google Scholar
• Jeffes EW. Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light. J. Am. Acad. Dermatol. 45, 96–104 (2001).
   PubMed Web of Science ®Google Scholar
• Jeffes EW. Levulan: the first approved topical photosensitizer for the treatment of acticic keratoses. J. Dermatol. Treat. 13(Suppl. 1), S19–S23 (2002).
   Web of Science ®Google Scholar
• Freeman M. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective randomized study. J. Dermatol. Treat. 14, 99–106 (2003).
   PubMedGoogle Scholar
• Parisier DM. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J. Am. Acad. Dermatol. 48, 227–232 (2003).
   PubMedGoogle Scholar
• Morton CA. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen’s disease. Br. J. Dermatol.135, 766–771 (1996).
   PubMed Web of Science ®Google Scholar
• Salim A, Leman JA, McColl JH, Chapman R, Morton CA. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen’s disease. Br. J. Dermatol.148(3), 539–543 (2003).
   PubMed Web of Science ®Google Scholar
• Svanberg K. Photodynamic therapy of non-melanoma malignant tumors of the skin using topical delta-amino levulinic acid sensitization and laser irradiation. Br. J. Dermatol.130, 743–751 (1994).
   PubMed Web of Science ®Google Scholar
• Lui H. Photodynamic therapy and non-melanoma skin cancer with topical aminolevulinic acid: a clinical and histologic study. Arch. Dermatol. 131(1), 737–738 (1995).
   PubMedGoogle Scholar
• Choudry K, Brooke RC, Farrar W, Rhodes LE. The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy. Br. J. Dermatol.149(1), 124–30 (2003).
   PubMedGoogle Scholar
• Soler AM, Warloe T, Berner A, Giercksky KE. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. Br. J. Dermatol.145, 467–471 (2001).
   PubMed Web of Science ®Google Scholar
• Morton CA, Brown SB, Collins S et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br. J. Dermatol.146, 552–567 (2002).
   PubMed Web of Science ®Google Scholar
• Bolgnia J, Jorizzo J, Rapini R. Photodynamic therapy. In: Dermatology. Volume 2. 135, 2127–2142, Mosby (2003).
   Google Scholar
• Knobler E. Current management strategies for cutaneous T-cell lymphoma. Clin. Dermatol. 22(3), 197–208 (2004).
   PubMed Web of Science ®Google Scholar
• Coors EA, von den Driesch P. Topical photodynamic therapy for patients with therapy-resistant lesions of cutaneous T-cell lymphoma. J. Am. Acad. Dermatol. 50(3), 363–367 (2004).
   PubMedGoogle Scholar
• Oleinick N, Antunez A, Clay M, Rihter B, Kenney M. New phthalocyanine photosensitizers for photodynamic therapy. Photochem. Photobiol. 57, 242–247 (1993).
   PubMedGoogle Scholar
• Ke M, Liang-yan X, Azzizudin K et al. Uptake of the silicon phthalocyanine Pc 4 and increased photodynamic sensitivity for Jurkat T-cells versus A431 epidermoid cells (2005) (In Press).
   Google Scholar
• Usuda J, Azizzudin K, Chiu SM, Oleinick NL. Association between the photodynamic loss of Bcl-2 and the sensitivity to apoptosis caused by phthalocyanine photodynamic therapy. Photochem. Photobiol. 78(1), 1–8 (2003).
   PubMed Web of Science ®Google Scholar
• Swick AR, Camouse M, McCormick TS et al. Succesful penetration of topically-applied silicon phthalocyanine photosensitizer Pc 4 and new Pc 4 salts into human skin. J. Invest. Dermatol. 122, A146 (2004) (Abstract).
   Google Scholar
• Taub AF. Photodynamic therapy for the treatment of acne: a pilot study. J. Drugs Dermatol. 3(Suppl. 6), S10–S14 (2004).
   PubMedGoogle Scholar
• Itoh Y, Ninomiya S, Ishibashi A. Photodynamic therapy for acne vulgaris with topical 5-aminolevulinic acid. Arch. Dermatol. 136, 1093–1095 (2000).
   PubMed Web of Science ®Google Scholar
• Itoh Y, Ninomiya Y, Tajima S, Ishibashi A. Photodynamic therapy of acne vulgaris with topical delta aminolevulininc acid and incoherent light in Japanese patients. Br. J. Dermatol.144, 575–579 (2001).
   PubMed Web of Science ®Google Scholar
• Hongcharu W. Taylor CR, Chang Y. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J. Invest. Dermatol. 115, 183–192 (2000).
   PubMed Web of Science ®Google Scholar
• Goldman MP, Boyce SM. A single center study of aminolevulinic acid and 417 nm photodynamic therapy in the treatment of moderate to severe acne vulgaris. J. Invest. Dermatol. 2, 393–396 (2003).
   Google Scholar
• Elman M, Slatkine M, Harth Y. The effective treatment of acne vulgaris by a high intensity narrow band 405–420 nm light source. J. Cosmet Laser Ther. 5, 111–117 (2003).
   PubMedGoogle Scholar
• Touma DJ, Guilchrest BA. Topical photodynamic therapy: a new tool in cosmetic dermatology. Semin. Cutan. Med. Surg. 22, 124–130 (2003).
   PubMed Web of Science ®Google Scholar